Pancreatic Cancer Research

ResearcherCreatv MicroTech (United States)No recent work listed

Daniel L. Adams

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1916-9637; OpenAlex author ID A5005317276. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

  1. CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer. Last author DOI 10.1371/journal.pone.0264763↗
  2. Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes. Last author DOI 10.1038/s41698-021-00161-8↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kirby P. Gardner · 2 shared papers, 2021–2022 · strength 0.37
  2. Mohammed Aldakkak · 2 shared papers, 2021–2022 · strength 0.37
  3. Susan Tsai · 2 shared papers, 2021–2022 · strength 0.37

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.